Aug. 23, 2019 Price forecast | 2 weeks: 6.67% | 1 month: 7.19% | 3 months: 12.13% | Premium Forecast


SYN stock forecast

Our latest prediction for Synthetic Biologics, Inc.'s stock price was made on the Aug. 23, 2019 when the stock price was at 0.40$.

In the short term (2weeks), SYN's stock price should outperform the market by 6.67%. During that period the price should oscillate between -8.55% and +18.75%.

In the medium term (3months), SYN's stock price should outperform the market by 12.13%. During that period the price should oscillate between -20.92% and +59.51%.


About Synthetic Biologics, Inc.

Synthetic Biologics, Inc. is a clinical stage company, which engages in the development of therapeutics to preserve the microbiome to protect and restore the health of patients. Its product portfolio includes SYN-010 and SYN-004. The SYN-010, which is intended to reduce the impact of methane-producing organisms in the gut microbiome to treat an underlying cause of irritable bowel syndrome with constipation. The SYN-004, which is designed to protect the gut microbiome from the effects of certain commonly used intravenous (IV) antibiotics for the prevention of C. difficile infection, antibiotic-associated diarrhea, and the emergence of antimicrobial resistance. The company was founded by Steven H. Kanzer in January 2001 and is headquartered in Rockville, MD.

At the moment the company doesn't generate any revenue.

On its last earning announcement, the company reported a loss of -2.74$ per share.

The book value per share is -1.71$

Synthetic Biologics, Inc. website


Three months stock forecastAug. 23, 2019


Financials

Revenue USD Gross Margin Operating Income Operating Margin Net Income Earnings Per Share Dividends Payout Ratio Shares Book Value Per Share Operating Cash Flow Cap Spending Free Cash Flow
- - -15M - -14M -2.74 - - 12M -1.71 -14M - -14M